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Eosinophils facilitate antigen-specific T-cell proliferation and
aggravate antigen-induced arthritis.
Taro SAIKA
Department of Immunology and Molecular Genetics, Kawasaki Medical School,
577 Matsushima, Kurashiki, 701-0192, Japan
ABSTRACT  In the pathophysiology of rheumatoid arthritis (RA), various types of cells, 
including macrophages, lymphocytes, neutrophils, mast cells, osteoclasts, chondrocytes, and 
fibroblast-like synoviocytes, contribute to the destructive process. Involvement of eosinophils 
in RA was first suggested by the presence of eosinophilic cationic protein in the synovial fluid. 
Later, infiltration of eosinophils in the synovium of RA and the increase of eotaxin in the sera of 
early RA were reported. Despite these indications, the precise role of eosinophils in RA remains 
unclear.
　In this study, we analyzed whether eosinophils are involved in antigen-induced arthritis (AIA). 
AIA utilizes Complete Freund's adjuvant (CFA) as an inducer of the Th1 immune response 
and heat-killed Bordetella pertussis as a Th2 immune response inducer. We then used flow 
cytometry to examine whether eosinophils were present in the knee synovium of animals 
subjected to AIA. The results revealed that the average total cell number in synovia injected 
with methylated BSA (mBSA) was 4.8-fold of that in control synovium injected with saline. The 
numbers of eosinophils in the synovium increased 10.8-fold compared with those in the controls. 
We also analyzed the gene expression of pro-inflammatory cytokines (IL-1β, IL-6, TNFα, and 
IL-17), Th1/Th2 cytokine (IFNγ and IL-13), and mediators that increase eosinophils (IL-5, IL-33, 
GM-CSF, CCL11, CCL24, CCL26, and RANTES) in the synovium of the knee joints. The result 
showed that the levels of IL-17 in the synovium injected with mBSA were significantly higher 
than those in the controls. In some antigen-challenged synovia, increased gene expression of 
IL-6 was observed. By contrast, expression of the other genes showed no consistent changes 
between synovia from knees with or without antigen challenge. To determine a definitive role for 
eosinophils in AIA, we used eosinophil-deficient ∆dblGATA mice for the antigen challenge. We 
found that the severity scores of arthritis in ∆dblGATA mice were milder than those in WT mice. 
To investigate whether eosinophils are involved in the adaptive immunity associated with AIA, 
we analyzed serum IgG and lymph node cell proliferation from both WT and ∆dblGATA mice. 
This revealed that the anti-mBSA IgG levels were similar in the two strains and that mBSA-
specific lymph node cell proliferation in ∆dblGATA mice was impaired. Together, these data 
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INTRODUCTION
   Eosinophils are leukocytes involved in innate 
immunity that are found in relatively low numbers 
within the blood (1-4% of total peripheral blood 
leukocytes). Mature eosinophils have a bilobed 
nucleus and eosinophil-specific granules in 
cytoplasm. The granules contain major basic protein, 
eosinophil peroxidase, eosinophilic cationic protein 
and eosinophil-derived neurotoxin. Eosinophils 
function as cytotoxic effector cells, are involved in 
the immune response to helminth infections, and 
play a role in allergic responses. However, it is 
increasingly clear that eosinophils have additional 
roles. For example, human eosinophils constitutively 
contain preformed Th1/Th2 cytokines (IFNγ/IL-4 
and IL-13) and immunoregulatory cytokines (IL-
6, TNFα, IL-10, and IL-12) and can secrete these 
mediators very rapidly during the immediate innate 
immune response. In doing so, the eosinophils 
are able to regulate the microenvironment, albeit 
by secreting lower amounts of inflammatory 
mediators when compared to T cells 1). Furthermore, 
eosinophils regulate inflammation and tissue-
remodeling via both by releasing cytotoxic 
eosinophil-specific granules and by secreting a large 
amount of cytokines and growth factors such as 
TGFβ, bFGF, and Th2 cytokines 2). 
   Rheumatoid arthrit is  (RA) is a systemic 
autoimmune disease characterized by hyperplasia 
of the synovium, with progressive chronic 
inflammation leading to joint destruction. The 
incidence of RA is approximately 1% worldwide, 
but its etiology and pathophysiology is not 
completely understood 3). RA is a polygenic disease 
and is caused by immunological disorders that 
develop from the synergistic actions of genetic and 
environmental factors 4). Clinical and experimental 
studies have implicated inflammatory cytokines 
such as tumor necrosis factor (TNF)α, IL-1β, 
and IL-6 in the pathophysiology of RA 2). In RA, 
CD4＋ T cells, B cells and macrophages infiltrate the 
synovium; this leads to hyperplasia of the intimal 
lining due to a marked increase in macrophage-like 
and fibroblast-like synoviocytes. Locally expressed 
degradative enzymes, including metalloproteinases, 
serine proteases, and aggrecanases, digest the 
extracellular matrix and destroy the articular 
structures 3, 5-10).
   Involvement of eosinophils in RA was first 
suggested by the presence of eosinophilic cationic 
protein in the synovial fluid 11). Subsequently, 
eosinophils were detected in 3 of 19 rheumatoid 
synovial specimens 12), and another prospective 
clinical study showed that 7.6% (15/197) of patients 
with RA had eosinophilia 13). Proteomic analysis of 
secreted proteins in the sera revealed an increase 
of eotaxin in early RA 14). Thus, despite these 
indicators, the actual role of eosinophils in RA 
remains unclear.
   Among the murine arthritis model systems for 
RA, even in the type II collagen-induce arthritis 
(CIA) model, which is most popular, there is almost 
no paper reporting the involvement of eosinophils. 
Recently, involvement of eosinophils in an arthritis 
model related to CIA was reported. In the transgenic 
mouse with the TCR gene specifically recognizing 
type II collagen, intraperitoneal injection of type 
II collagen induced chronic arthritis, which was 
associated with eosinophil infiltration dependent on 
IL-5 15). Although this special system provided the 
indicate that eosinophils play roles in the support of antigen-specific T cell growth responses, 
and promotion of arthritis.
 doi：10.11482/KMJ-E40（1）13　(Accepted on October 10, 2013)
Key words： Mouse, Synovium, ∆dblGATA, T cell, Acquired immunity, Rheumatoid arthritis
15Saika T : Eosinophil function in acquired immunity in murine arthritis
concept that eosinophils could induce destructive 
arthritis, conventional CIA is generally not suitable 
for the analysis of eosinophils because its immune 
response is strongly skewed to Th1 by using 
Complete Freund's adjuvant (CFA).  Thus, we 
took advantage of another murine arthritis model, 
antigen-induced arthritis (AIA) that utilizes CFA 
as an inducer of the Th1 immune response and 
heat-killed Bordetella pertussis as a Th2 immune 
response inducer. In AIA, roles for cytokines have 
been intensively examined. For example, IL-6 
plays a key role in the development of arthritis, 
particularly with regard to bone destruction 16), 
whereas IFNγ shows anti-inflammatory properties 
during the initial phase of AIA by inhibition of IL-
17 17). However, there are no published reports of 
investigations into whether eosinophils contribute to 
pathogenesis of AIA.
   In this study, we examined the involvement of 
eosinophils in AIA by performing detailed analyses 
of the synovium in both WT and eosinophil-
deficient (∆dblGATA) mice. 
MATERIALS  AND  METHODS
Animals 
   The animal experiments in this study were 
approved by the committees in the Kawasaki 
Medical School for the safety of recombinant 
DNA experiments (No.11-11), and for the animal 
experiments (No.12-025, 13-061). The eosinophil-
deficient ∆dblGATA mice in a C57BL/6 background 
were kindly provided by Dr. S. H. Orkin 18). 
C57BL/6 mice were purchased from Nihon SLC 
(Sizuoka, Japan). ∆dblGATA mice and C57BL/6 
were bred and housed in a temperature-controlled 
room and given free access to water and food. 
Induction of arthritis 
   AIA was performed by following a previously 
described protocol 19). Briefly, 8-12 week-old 
mice were immunized on day 0 and 7 with 100 µg 
methylated BSA (Sigma, Tokyo, Japan) emulsified 
in 0.1 ml CFA containing 200 µg mycobacterial 
strain H37RA (Difco, Tokyo, Japan) by intradermal 
injection at the four footpads; 2 × 109 heat-killed 
Bordetella pertussis (Cosmo Bio Co., Tokyo, Japan) 
were also injected intraperitoneally. On day 21, 100 
µg of mBSA in 10 µl of saline was injected into the 
left knee joint. As a control, the same volume of 
saline was injected into the right knee joint and mice 
were sacrificed for analysis on day 35 after priming.
Histological examination 
   The knees were dissected and fixed in 10% 
buffered formalin for 1 d. Fixed tissues were 
decalcified with 10% formic acid for 1 week, 
dehydrated, and embedded in paraffin. Sections of 
the whole knee joint were stained with hematoxylin-
eosin. The slides were evaluated histologically 
by two independent observers, and the grade of 
arthritis was scored from 0 to 4 according to the 
intensity of lining layer hyperplasia, mononuclear 
cell infiltration, and pannus formation as described 
previously 19). The scores were defined as follows: 
0, normal knee joint; 1, normal synovium with 
occasional mononuclear cells; 2, definite arthritis, 
a few layers of flat to rounded synovial lining 
cells and scattered mononuclear infiltrates; 3, clear 
hyperplasia of the synovium with three or more 
layers of loosely arranged lining cells and dense 
infiltration with mononuclear cells; and 4, severe 
synovitis with pannus and erosion of articular 
cartilage and subchondral bone. 
Cell preparation
   On day 35 after priming, mice were sacrificed and 
the brachial lymph nodes were removed and teased 
with slide glass. The synovia were removed from 
the knee joints, minced, and digested in RPMI1640 
containing 1 mg/ml collagenase D (Roche, Tokyo, 
Japan) at 37 ℃ for 3 h. Single-cell suspension was 
prepared by gentle pipetting and filtration through a 
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nylon mesh. 
Flow cytometry analysis
   Multi-color staining for flow cytometry analysis 
was performed as described previously 20), and 
cells were analyzed using a FACS CantoⅡ flow 
cytometer (Becton Dickinson, Tokyo, Japan) and 
BD FACS Diva software. Monoclonal antibodies 
used were as follows: FITC-conjugated anti-Ly-
6G and Ly-6C mAb (Gr-1, clone; RB6-8C5), PE-
conjugated anti-siglec F mAb (BD Pharmingen, 
Tokyo, Japan); PerCP-Cy5.5-conjugated anti- 
CD3ε (145-2C11) mAb, PerCP-Cy5.5-conjugated 
anti-CD19 (6D5), PerCP-Cy5.5-conjugated anti-
NK1 .1  mAb (PK136)  (eBioscience,  Tokyo, 
Japan), APC-conjugated anti-F4/80 mAb (BM8) 
(eBioscience); APC-Cy7-conjugated anti-CD19 
mAb (BioLegend, Tokyo, Japan); eFluor-450-
conjugated anti-CD11b mAb (M1/70) (eBioscience). 
Non-specific binding to FcγR was blocked with 
anti-CD16/32 mAb (2.4G2) and 5% heat inactivated 
rat serum.
Quantitative PCR
   Total RNA was isolated from the synovium of 
the knee joints using TRIzol (Invitrogen, Tokyo, 
Japan). RNA samples were treated with DNase I 
(Sigma). cDNA was synthesized with ReverTra Ace 
qPCR RT Kit (Toyobo, Osaka, Japan) following the 
manufacturer’s instructions. cDNA samples were 
amplified with specific primers in the Power SYBR 
Green PCR Master Mix (Applied Biosystems, 
Tokyo, Japan) and run on a ABI 7300 or 7500 cycler 
(Applied Biosystems). The specific PCR primers 
were designed using Universal Primer Design Tools 
available on the web site of Roche. The sequences 
for the primers (sense, anti-sense) were as follows: 
IL-1β,  5’-TTGACGGACCCCAAAAGAT-3’
and 5’-GAAGCTGGATGCTCTCATCTG-3’; IL-
5, 5’-ACATTGACCGCCAAAAAGAG-3’and 
5’-ATCCAGGAACTGCCTCGTC-3’; IL-6, 5’
-GCTACCAAACTGGATATAATCAGGA-3’and 
5’-CCAGGTAGCTATGGTACTCCAGAA-3’; IL-
13, 5’-CCTCTGACCCTTAAGGAGCTTAT-3’
and 5’-CGTTGCACAGGGGAGTCT-3’; IL-33, 
5’-GGTGAACATGAGTCCCATCA-3’and 5’
-CGTCACCCCTTTGAAGCTC-3’; IFNγ, 5’
-ATCTGGAGGAACTGGCAAAA-3’and 5’
-TTCAAGACTTCAAAGAGTCTGAGGTA-3’; 
TNFα, 5’-TGCTGGGAAGCCTAAAAGG-3’
and 5’-CGAATTTTGAGAAGATGATCCTG-3’; 
RANTES, 5’-CTACTCCCACTCCGGTCCT-3’ 
and 5’-GATTTCTTGGGTTTCGTGGTC-3’; 
CCL11, 5’-AGAGCTCCACAGCGCTTCT-3’
a n d  5’- G C A G G A A G T T G G G AT G G A -3’; 
CCL24 ,  5’-GCAGCATCTGTCCCAAGG-3’
and  5’-GCAGCTTGGGGTCAGTACA-3’; 
CCL26, 5’-GCACCAGTGACGGTGTGATA-3’
and 5’-TGAATCTCTGCACCCATTTG-3’; β
-actin, 5’-CTAAGGCCAACCGTGAAAAG-3’
and 5’-ACCAGAGGCATACAGGGACA-3’. The 
expression levels of target cDNAs were normalized 
to the endogenous transcription levels of the β
-actin.
Measurement of serum anti-mBSA IgG
   Se ra  were  co l lec ted  on  days  0  (be fore 
immunization), 7, and 14. Anti-mBSA IgG levels 
were measured by ELISA as described previously 16). 
Further, 96-well plates were coated with 100 µl of 5 
µg/ml mBSA (Sigma) in coating buffer (Carbonate-
bicarbonate buffer pH9.6) for 1 h at RT and blocked 
by incubation with 0.1% goat serum in PBS for 1 h 
at RT. After washing 3 times with PBS containing 
0.1% Tween 20 (washing buffer), a 100-µl aliquot 
of mouse serum diluted 40-fold in PBS was applied 
and incubated for 30 min at RT. After another 
wash, 100 µl of goat anti-mouse IgG conjugated 
with alkaline phosphatase (SouthernBiotech, 
Birmingham, AL) (1:1000 dilution) was added 
and incubated for 30 min at RT. The plates were 
washed 3 times and p-nitrophenylphosphate (0.1 
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µg/ml in substrate buffer; 0.05 M NaHCO2, 10 mM 
MgCl2, pH 9.8) was applied in each well. Color 
development was monitored by absorbance at 405 
nm with Varioscan (Thermo Electron Corporation, 
Yokohama, Japan).
Proliferative response of the lymph node cells
   Mice were immunized with mBSA twice on days 
0 and 7 by the same protocol with the induction of 
AIA. On day 14, the brachial lymph nodes were 
removed and single lymph node cell suspensions 
were prepared. Lymph node cells (5 × 105 cells/
well) were cultured in 96-well plates with 0.1 ml 
of DMEM supplemented with 1% mouse serum 
and antibiotics in the absence or presence of 
either mBSA (100 µg/ml) or hamster anti-mouse 
CD3ε mAb (145-2C11; 1.0 µg/ml) for 72 h. Cell 
proliferation was measured using the MTT assay 
(Roche) 21).
Statistical analysis
   Statistical significance for all experiments was 
analyzed using the Mann-Whitney U-test run in 
StatMate 4.01 software (ATMS Co. Ltd., Tokyo, 
Japan).
RESULTS
Marked increases of various hematopoietic cells in 
synovia after intra-articular injection of mBSA
   To investigate whether eosinophils are associated 
with development of arthritis, we analyzed cells 
in the synovium of mice subjected to AIA. Flow 
cytometrical definitions for myeloid cells are as 
reported by Chu et al. 22). Briefly, lymphoid cells 
expressing either CD3ε, CD19 or NK1.1 were 
gated out to enrich for myeloid cells. Among the 
CD3ε-CD19-NK1.1- myeloid fraction, the Gr-
1hiCD11b+ fraction contains neutrophils, whereas Gr-
1loF4/80+ fraction is further divided into 3 fractions: 
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Fig. 1.　Marked increases in the number of eosinophils in the synovia of mice subjected to AIA. Identiﬁcation 
of monocytes, neutrophils, eosinophils, and eosinophil precursors by multicolor flow cytometry analysis (A). 
Total cell numbers in the synovium (B) and the individual cell populations in the synovium (C). Numbers of cells 
prepared from the synovium injected with saline (white circle) and mBSA (black circle) are shown. The data 
of each individual mouse are connected with a line. The circles and horizontal bars indicate the values for each 
mouse and the average, respectively.
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CD11bintSiglecF+ (eosinophils), CD11bintSiglecF- 
(eosinophil precursors), and CD11 loSiglecF- 
(monocytes) (Fig. 1A).
   The average total cell number in synovia injected 
with mBSA increased 4.8-fold from that of the 
synovia injected with saline as control (Fig. 1B). 
The majority of these cells were monocytes, and 
others include, T cells (CD3ε+), neutrophils, 
eosinophils, and B cells (CD19+) were also present. 
The number of eosinophils in the Ag-challenged 
synovia increased 10.5-fold compared with the 
control (Fig. 1C). The increase of eosinophils was 
the highest among the mature hematopoietic cells 
in the synovia. Although the eosinophils accounted 
for only a minor fraction of the total cells, their 
frequency in the arthritic synovium was almost 
equivalent to that of neutrophils at day 35. Taken 
together, these data suggest that eosinophils may 
play a role in the pathophysiology of AIA.
Marked increase of IL-17 gene expression in the 
synovium after intra-articular injection of mBSA
   To investigate which cytokines are associated 
with the inflammatory response and the increase of 
eosinophils in the AIA synovium, we quantitatively 
analyzed the expression of a panel of genes. This 
included pro-inflammatory cytokines (IL-1β, IL-6, 
TNFα, and IL-17), Th1/Th2 cytokines (IFNγ and 
IL-13), and mediators that induce a local increase of 
eosinophils (GM-CSF, IL-5, IL-33, CCL11, CCL24, 
CCL26, and RANTES). This revealed that levels 
of IL-17 were significantly higher in the synovia 
injected with mBSA than in controls. Although 
there was no overall significant difference in IL-6 
levels between groups with or without Ag challenge, 
2 of 5 mice showed more than 10-fold increase 
in this cytokine from the levels in the controls. 
The expression of mediators affecting eosinophils 
showed no consistent changes between the right and 
left synovium of the knee joint (Fig. 2). These data 
suggest that IL-17 and/or IL-6 likely play pivotal 
roles in the inflammatory component of AIA.
Arthritis of eosinophil-deficient mice was milder 
than WT mice
   The joints of WT mice injected with mBSA 
developed severe arthritis with marked synovial 
hyperplasia, mononuclear cell infiltration, and 
erosions of the articular cartilage and bone (Fig. 3B) 
unlike the control joints injected with saline (Fig. 
3A). To determine the importance of eosinophils 
in AIA, we utilized eosinophil-deficient mice, 
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Fig. 2.　Expression of the IL-17 gene increased in the synovium after intra-articular injection of mBSA. The 
relative amount of each gene from samples of synovium injected with saline (white circle) and mBSA (black 
circle) are shown. The expression level of each gene was normalized to the amount of β-actin in the synovium 
from one control joint injected with saline alone.
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∆dblGATA, in the AIA model. The arthritis in 
∆dblGATA mice was milder than in WT mice, 
especially with regard to the degree of cellular 
infiltration into synovial tissue (Fig. 3-D). As shown 
in Table 1, the majority of arthritis grades for WT 
was 4, whereas that of ∆dblGATA was 3, clearly 
indicating that eosinophils play roles in promoting 
arthritis in AIA. 
Antigen-specific response of T cells but not B cells 
is impaired in ∆dblGATA mice
   A previous study showed that alum treatment 
induced eosinophil recruitment to the spleen and 
that lack of eosinophils led to reduced antibody 
production during the thymus-dependent antigen 
response 23). To determine the locations at which 
eosinophil activity affects the development of 
arthritis, we analyzed the acquired humoral immune 
WT dblGATA 
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Saline 
mBSA 
Fig. 3 
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Fig. 3.　Arthritis in eosinophil-deﬁcient mice was milder than WT mice. WT mice developed severe arthritis 
with marked synovial hyperplasia, mononuclear cell inﬁltration (B) compared with the control (A). Arthritis of 
∆dblGATA mice had a less pronounced inﬁltration of inﬂammatory cells in the synovial tissue (D). The knee joint 
of ∆dblGATA mice injected with saline (C) is almost same as that of WT mice (B). Bars =1mm.
Table 1. Histological scores for AIA in the eosinophil-deﬁcient and WT mice. 
The numbers of mice in each histological grade of AIA
Grade Histological characteristics WT ∆dblGATA
0 normal knee joint. 0 0
1 normal synovium with occasional mononuclear cells. 0 0
2 deﬁnite arthritis, a few layers of ﬂat to rounded synovial lining cells 
and scattered mononuclear inﬁltrates.
0 1
3 clear hyperplasia of the synovium with three or more layers of 
loosely arranged lining cells and dense inﬁltration with mononuclear 
cells.
1 3
4 severe synovitis with pannus and erosions of articular cartilage and 
subchondral bone. 3 1
Both groups were immunized in the standard manner and the mice were sacriﬁced 35 days after priming (14 
days after injection of mBSA to the joint space).
The histopathological characteristics of the knee joints scored from 0 to 4 are indicated.
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response by measuring serum mBSA-specific 
IgG as well as the cellular immune response by 
quantifying mBSA-specific proliferation of lymph 
node cells. As shown in Fig. 4, measurement of 
serum anti-mBSA IgG levels revealed no difference 
between ∆dblGATA and WT mice on days 7 and 
14 after immunization. On the other hand, mBSA-
specific proliferative responses of lymph node cells 
from ∆dblGATA mice were reduced to less than half 
of those from WT mice. No difference was observed 
in proliferation induced by anti-CD3ε antibody 
between ∆dblGATA and WT mice, which indicates 
that the TCR-mediated T cell response itself is 
normal in the eosinophil-deficient mice. FACS 
analysis revealed no difference in the ratio of either 
CD3/CD19 or CD4/CD8 in the lymph node cells 
between the two groups. Thus, eosinophils appear to 
have a functional role in the antigen-specific T cell 
responses during AIA.
DISCUSSION
   In this study, we report that the number of 
eosinophils increases in the synovium of mice 
subjected to AIA. Addit ionally,  our use of 
eosinophil-deficient mice underscores a critical 
role for these cells in AIA pathology. Furthermore, 
we showed that the antigen-specific T-cell growth 
responses, but not the B-cell humoral immune 
responses, were impaired in the eosinophil-
deficient mice. Owing to the selective increase 
in IL-17 expression in the synovium at day 35, 
we speculate that eosinophils may also regulate 
the Th17 cell development. A marked increase of 
IL-6 expression in some of the antigen-challenged 
synovia suggests that the axis of IL-6/gp130/STAT3/
Th17 might contribute to the late phase of AIA. 
Additionally, eosinophils secrete various cytokines 2) 
and some of them (IL-1β, IL-2, and IL-6) could 
facilitate T cell proliferation. Thus, it will be 
interesting to examine the profile of cytokines in the 
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Fig. 4.　Antigen-speciﬁc responses of T cells but not B cells were impaired in eosinophil-deﬁcient mice. Mice 
were immunized with mBSA twice on days 0 and 7 according to the same protocol used for induction of AIA. 
(A) Sera were collected before and 7 or 14 d after ﬁrst immunization. The titers of antibodies (IgG class) against 
mBSA were measured by ELISA. White and black circles indicate the values of WT mice and ∆dblGATA mice, 
respectively. (B) 7 d after the second immunization (Day 14 after priming) with mBSA, the brachial lymph node 
cells were prepared and cultured at 5×105 cells/well in the absence or presence of either mBSA (100 µg/ml) or 
anti-CD3ε mAb (1.0 µg/ml) for 72 h. The proliferative response was measured using the MTT assay. Data are 
representative of 2 independent experiments. White (WT mice) and black (∆dblGATA mice) bars indicate the 
average values of triplicate and standard deviations are shown.
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supernatant of T cells stimulated in vitro.
   T cell proliferation and differentiation are 
regulated by signals delivered not only through 
the TCR recognizing the antigen peptide, but also 
by cytokines and co-stimulatory molecules of 
antigen presenting cells (APCs) such as dendritic 
cells 24, 25). Our results suggest that eosinophils 
posi t ively regulate  ant igen-specif ic  T cel l 
proliferation. A previous study by others showed 
that eosinophils act as APCs in an ovalbumin-
induced bronchial asthma model 26). Similar to this, 
we speculate that eosinophils may also play the role 
of APCs in AIA. 
   To find the functional interaction between 
eosinophils and T cells, future studies will focus in 
the kinetics of eosinophil and T cell in the synovium 
during priming or after antigen challenge. Since 
eosinophils contain cytotoxic granule proteins and 
various secretory mediators, including cytokines, 
chemokines, growth factors and lipid, analyses of 
the production and release of such mediators by 
eosinophils in the synovium or the lymph nodes in 
AIA will also be informative.
   In this study, the numbers of specimens for 
histological analyses were limited, but they 
showed clear but not significant difference in the 
severity of arthritis due to eosinophil deficiency. 
We are currently extending this study to a larger, 
comprehensive one to clarify the relationship 
between the gene expression in the synovia, the 
cellular localization especially of T cells and 
eosinophils, and the histological grades of arthritis.
   Although it has been difficult to understand 
the roles of eosinphils in the RA synovia, our 
results could provide an intriguing possibility that 
eosinophils involve in the pathophysiology of RA 
by facilitating T cell proliferation to certain antigens 
including self-antigens.
ACKNOWLEDGEMENT
   I appreciate the supervision of this work by Prof. 
Katsuhiko Ishihara, and the encouragement by 
Prof. Tamotsu Harada. I also thank to Drs. Hideya 
Igarashi and Ayano Yahagi for their helpful advice, 
and to Ms. Yuka Kenmotsu for her technical 
assistance. We appreciate Drs. S.H. Orkin, C.Gerard, 
and B. Lu for ∆dblGATA mouse. This study was 
partly supported by Reasearch Project Grants for 
Graduate Students of Kawaski Medical School (24-
7).
REFERENCES
１） Spencer LA, Szela CT, Perez SA, Kirchhoffer CL, 
Neves JS, Radke AL, Weller PF : Human eosinophils 
const i tut ively express mult iple  Th1 ,  Th2 ,  and 
immunoregulatory cytokines that are secreted rapidly 
and differentially. J Leukoc Biol 85: 117-123, 2009
２） Shamri R, Xenakis JJ, Spencer LA : Eosinophils in 
innate immunity: an evolving story. Cell Tissue Res 343: 
57-83, 2011
３） Firestein GS : Evolving concepts of rheumatoid arthritis. 
Nature 423: 356-361, 2003
４） Ishihara K, Sawa S, Ikushima H, et al. : The point 
mutation of tyrosine 759 of the IL-6 family cytokine 
receptor gp130 synergizes with HTLV-1 pX in promoting 
rheumatoid arthritis-like arthritis. Int Immunol 16: 455-
465, 2004
５） Mulherin D, Fitzgerald O, Bresnihan B : Synovial 
tissue macrophage populations and articular damage in 
rheumatoid arthritis. Arthritis Rheum 39: 115-124, 1996
６） Wright HL, Moots RJ, Bucknall RC, Edwards SW : 
Neutrophil function in inflammation and inflammatory 
diseases. Rheumatology (Oxford) 49: 1618-1631, 2010
７） Xu D, Jiang HR, Kewin P, et al. : IL-33 exacerbates 
antigen-induced arthritis by activating mast cells. Proc 
Natl Acad Sci U S A 105: 10913-10918, 2008
８） Cope AP, Schulze-Koops H, Aringer M : The central role 
of T cells in rheumatoid arthritis. Clin Exp Rheumatol 
25: S4-11, 2007
９） Otero M, Goldring MB : Cells of the synovium in 
rheumatoid arthritis. Chondrocytes. Arthritis Res Ther 9: 
220, 2007
10） Schett G : Cells of the synovium in rheumatoid arthritis. 
Osteoclasts. Arthritis Res Ther 9: 203, 2007
11） Hällgren R, Bjelle A, Venge P : Eosinophil cationic 
protein in inflammatory synovial effusions as evidence 
22 Kawasaki Medical Journal
of eosinophil involvement. Ann Rheum Dis 43: 556-562, 
1984
12） Tetlow LC, Woolley DE : Eosinophils are an insignificant 
cellular component of rheumatoid synovium in patients 
with late stage disease: comparative distributions with 
mast cells and macrophages. Ann Rheum Dis 55: 548-
551, 1996
13） Kargili A, Bavbek N, Kaya A, Koşar A, Karaaslan Y : 
Eosinophilia in rheumatologic diseases: a prospective 
study of 1000 cases. Rheumatol Int 24: 321-324, 2004
14） Hueber W, Tomooka BH, Zhao X, et al. : Proteomic 
analysis of secreted proteins in early rheumatoid 
arthritis: anti-citrulline autoreactivity is associated with 
up regulation of proinflammatory cytokines. Ann Rheum 
Dis 66: 712-719, 2007
15） Bockermann R, Holmdahl R : Type II collagen without 
adjuvant induces eosinophilic arthritis. Eur J Immunol 
37: 540-548, 2007
16） Ohshima S, Saeki Y, Mima T, et al. : Interleukin 6 
plays a key role in the development of antigen-induced 
arthritis. Proc Natl Acad Sci U S A 95: 8222-8226, 1998
17） Irmler IM, Gajda M, Bräuer R: Exacerbation of antigen-
induced arthritis in IFN-gamma-deficient mice as a 
result of unrestricted IL-17 response. J Immunol 179: 
6228-6236, 2007
18） Yu C, Cantor AB, Yang H, Browne C, Wells RA, 
Fujiwara Y, Orkin SH : Targeted deletion of a high-
affinity GATA-binding site in the GATA-1 promoter 
leads to selective loss of the eosinophil lineage in vivo. J 
Exp Med 195: 1387-1395, 2002
19） Brackertz D, Mitchell GF, Mackay IR : Antigen-induced 
arthritis in mice. I. Induction of arthritis in various 
strains of mice. Arthritis Rheum 20: 841-850, 1977
20） Ishihara K, Kobune Y, Okuyama Y, Itoh M, Lee BO, 
Muraoka O, Hirano T : Stage-specific expression of 
mouse BST-1/BP-3 on the early B and T cell progenitors 
prior to gene rearrangement of antigen receptor. Int 
Immunol 8: 1395-1404, 1996
21） Liu  Y,  Peterson DA, Kimura H,  Schuber t  D : 
Mechanism of cellular 3-(4,5-dimethylthiazol-2- yl)-
2,5-diphenyltetrazolium bromide (MTT) reduction. J 
Neurochem 69: 581-593, 1997
22） Chu VT, Fröhlich A, Steinhauser G, Scheel T, Roch T, 
Fillatreau S, Lee JJ, Löhning M, Berek C : Eosinophils 
are required for the maintenance of plasma cells in the 
bone marrow. Nat Immunol 12: 151-159, 2011
23） Wang HB, Weller PF : Pivotal advance: eosinophils 
mediate early alum adjuvant-elicited B cell priming and 
IgM production. J Leukoc Biol 83: 817-821, 2008
24） Schwartz RH : A cell culture model for T lymphocyte 
clonal anergy. Science 248: 1349-1356, 1990
25） Bour-Jordan H, Blueston JA : CD28 function: a balance 
of costimulatory and regulatory signals. J Clin Immunol 
22: 1-7, 2002
26） Shi HZ, Humbles A, Gerard C, Jin Z, Weller PF : 
Lymph node trafficking and antigen presentation by 
endobronchial eosinophils. J Clin Invest 105: 945-953, 
2000
